2009
DOI: 10.1289/ehp.11728
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Activity–Dependent Regulation of Cell Communication by Perfluorinated Fatty Acids using in Vivo and in Vitro Model Systems

Abstract: BackgroundPerfluoroalkanoates, [e.g., perfluorooctanoate (PFOA)], are known peroxisome proliferators that induce hepatomegaly and hepatocarcinogenesis in rodents, and are classic non-genotoxic carcinogens that inhibit in vitro gap-junctional intercellular communication (GJIC). This inhibition of GJIC is known to be a function of perfluorinated carbon lengths ranging from 7 to 10.ObjectivesThe aim of this study was to determine if the inhibition of GJIC by PFOA but not perfluoropentanoate (PFPeA) observed in F3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
51
1
3

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 62 publications
(56 citation statements)
references
References 49 publications
(79 reference statements)
1
51
1
3
Order By: Relevance
“…Because tumor formation requires loss of homeostasis and many tumor promoters inhibit GJIC, it has been hypothesized that GJIC might play a role in carcinogenesis (Trosko et al, 1998). PFOA has been demonstrated to inhibit GJIC in liver cells in vitro and in vivo (Upham et al, 2009). However, inhibition of GJIC is a widespread phenomenon, and the effect by PFOA was neither species-nor tissue-specific.…”
Section: Carcinogenicity Hesd and Iarc Descriptionsmentioning
confidence: 99%
“…Because tumor formation requires loss of homeostasis and many tumor promoters inhibit GJIC, it has been hypothesized that GJIC might play a role in carcinogenesis (Trosko et al, 1998). PFOA has been demonstrated to inhibit GJIC in liver cells in vitro and in vivo (Upham et al, 2009). However, inhibition of GJIC is a widespread phenomenon, and the effect by PFOA was neither species-nor tissue-specific.…”
Section: Carcinogenicity Hesd and Iarc Descriptionsmentioning
confidence: 99%
“…Peroxisome induced proliferation and the resulting activation of a nuclear receptor peroxisome proliferator-activated receptor  (PPAR) have also been proposed as a mechanism for tumor induction and for the immune and hormonal changes seen in rodents . Other proposed mechanism for tumor promotion is by inhibition of gap-junctional intercellular communication (GJIC) (Upham et al, 2009). GJIC plays a vital role in maintaining tissue homeostasis, and disruption of gap junction function can lead to diseased states such as tumorigenesis.…”
Section:  Hepatotoxicitymentioning
confidence: 99%
“…GJIC plays a vital role in maintaining tissue homeostasis, and disruption of gap junction function can lead to diseased states such as tumorigenesis. PFOA was shown to decrease GJIC activity in the liver of rats treated for both acute and long-term dosing (Upham et al, 2009). …”
Section:  Hepatotoxicitymentioning
confidence: 99%
“…As for many other EDCs, interactions with nuclear sex hormone receptors and their ligand-dependent transcription factor activity (so-called genomic signaling mechanism) have been implicated as the principal molecular mechanism responsible for endocrine disrupting activity of MXC and VIN (Manikkam et al, 2014;Ozgyin et al, 2015;van Ravenzwaay et al, 2013). Although MXC is a weak estrogen receptor (ER) agonist, its hydroxylated metabolites, such as HPTE (2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane), are potent ERa agonists and weak antagonists to both ERß and androgen receptor (AR) (Gaido et al, 2000).…”
mentioning
confidence: 99%
“…These effects, which are relevant for transcriptional and epigenetic control of gene expression and normal cell behavior (Trosko, 2011), were studied in a rat liver epithelial cell line WB-F344. This cell line is a well-established in vitro model for assessment of GJIC and mechanistic studies in responses to environmental contaminants (Sovadinova et al, 2015;Upham et al, 2007Upham et al, , 2008, which has been validated by in vivo studies (Sai et al, 2000;Upham et al, 2009) and matches the most extensively used rodent model system, F344 rats, in the National Toxicology Program. Both of these EDCs exhibited dose, time and mechanistic differences on GJIC, MAPKs, and phospholipase C, which were elicited by the parental compounds and occurred independently of ER-or AR-mediated genomic mechanisms.…”
mentioning
confidence: 99%